IP Library Granted Patent US 12,564,665
Granted Patent B2
US 12,564,665 · App. 18/401,994 · Granted Mar 3, 2026

Dialysis apparatus including therapy prescription selection

Inventors: Robert W. Childers (New Port Richey, FL); Alex Anping Yu (Safety Harbor, FL); Borut Cizman (Highwood, IL)
Assignees: Vantive US Healthcare LLC; Vantive Health GMBH
A61M1/287A61M1/155A61M1/159A61M1/28A61M1/282G06Q10/087G16H20/10G16H20/40A61M1/1522A61M1/1524A61M2205/12A61M2205/3553A61M2205/3584A61M2205/52G16H15/00G16H40/20G16H50/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,564,665
App. No.
18/401,994
Granted
Mar 3, 2026
Kind
B2
Abstract

An automated peritoneal dialysis apparatus includes at least one pump and a memory device configured to simultaneously store a first standard ultrafiltration (“UF”) therapy prescription with a longer duration and a lower dextrose concentration and a second standard UF therapy prescription with a shorter duration and a higher dextrose concentration. A logic implementer of the automated peritoneal dialysis apparatus is programmed to receive a patient weight value and determine a weight difference between the patient weight value and at least one prior patient weight value. When the weight difference is below a threshold, the logic implementer causes the first standard UF therapy prescription and the second standard UF therapy prescription to be displayed as possible options for selection and when the weight difference is above the threshold, the logic implementer prevents the second standard UF therapy prescription from being displayed as a possible option for selection.

Claims (38)

1 . An automated peritoneal dialysis apparatus comprising:

at least one pump;

a memory device configured to simultaneously store a first standard ultrafiltration (“UF”) therapy prescription with a longer duration and a lower dextrose concentration and a second standard UF therapy prescription with a shorter duration and a higher dextrose concentration; and

a logic implementer programmed to:

receive a patient weight value,

determine a weight difference between the patient weight value and at least one prior patient weight value,

when the weight difference is below a threshold, cause the first standard UF therapy prescription and the second standard UF therapy prescription to be displayed as possible options for selection,

when the weight difference is above the threshold, prevent the second standard UF therapy prescription from being displayed as a possible option for selection,

receive, via a user interface, a selection of the first standard UF therapy prescription or the second standard UF therapy prescription, and

operate the at least one pump to perform the selected first standard UF therapy prescription or the second standard UF therapy prescription.

2 . The automated peritoneal dialysis apparatus of claim 1 , wherein the logic implementer is further programmed to:

display a prompt indicating that a first solution having a first formulation including a lower dextrose concentration is to be placed in fluid communication with the at least one pump when the first standard UF therapy prescription is selected via the user interface; and

display a prompt indicating that a second solution having a second formulation including a higher dextrose concentration is to be placed in fluid communication with the at least one pump when the second standard UF therapy prescription is selected via the user interface.

3 . The automated peritoneal dialysis apparatus of claim 1 , further comprising:

a first valve placed between the at least one pump and a first container including a first solution having a first formulation including a lower dextrose concentration; and

a second valve placed between the at least one pump and a second container including a second solution having a second formulation including a higher dextrose concentration.

4 . The automated peritoneal dialysis apparatus of claim 3 , wherein the logic implementer is further programmed to:

(i) open the first valve when the first standard UF therapy prescription is selected via the user interface; and

(ii) open the second valve when the second standard UF therapy prescription is selected via the user interface.

5 . The automated peritoneal dialysis apparatus of claim 3 , wherein at least one of a fluid carrying portion of the first and second valves or a fluid carrying portion of the at least one pump is provided in a disposable cassette.

6 . The automated peritoneal dialysis apparatus of claim 3 , wherein the first container includes a first unique identifier that is indicative of the first formulation and the second container includes a second unique identifier that is indicative of the second formulation,

the automated peritoneal dialysis apparatus further comprising a reader to read the first unique identifier and the second unique identifier.

7 . The automated peritoneal dialysis apparatus of claim 6 , wherein the logic implementer is further programmed to generate an alarm or an alert when the first formulation indicated by the first unique identifier cannot be used for the first standard UF therapy prescription or the second formulation indicated by second unique identifier cannot be used for to the second standard UF therapy prescription.

8 . The automated peritoneal dialysis apparatus of claim 1 , wherein the logic implementer is further programmed to:

receive the first standard UF therapy prescription and the second standard UF therapy prescription from a server; and

store the first standard UF therapy prescription and the second standard UF therapy prescription to the memory device.

9 . The automated peritoneal dialysis apparatus of claim 1 , wherein the memory device is further configured to store a low UF therapy prescription, a first high UF therapy prescription with a shorter duration and a higher dextrose concentration, and a second high UF therapy prescription with a shorter duration and a higher dextrose concentration.

10 . The automated peritoneal dialysis apparatus of claim 9 , wherein the logic implementer is further programmed to when the weight difference is above the threshold, prevent the first high UF therapy prescription and the second high UF therapy prescription from also being displayed as possible options for selection.

11 . The automated peritoneal dialysis apparatus of claim 9 , wherein the logic implementer is further programmed to after selection of the low UF therapy prescription via the user interface:

identify a formulation level of a third solution specified by the low UF therapy prescription;

determine a first amount of pumping by the at least one pump needed to pump a first solution to form the third solution having the specified formulation level, the first solution having a first formulation including a lower dextrose concentration;

determine a second amount of pumping by the at least one pump needed to pump a second solution to form the third solution having the specified formulation level, the second solution having a second formulation including a higher dextrose concentration; and

operate the at least one pump to proportionally perform the first amount of pumping and the second amount of pumping to form the third solution.

12 . The automated peritoneal dialysis apparatus of claim 11 , further comprising a patient line in fluid communication with the at least one pump, the logic implementer further programmed to pump the first and second solutions proportionally through the patient line to a patient's peritoneum.

13 . The automated peritoneal dialysis apparatus of claim 11 , wherein the first amount of pumping includes a first number of pump strokes and the second amount of pumping includes a second number of pump strokes.

14 . The automated peritoneal dialysis apparatus of claim 11 , wherein the first and second solutions are mixed in a container to form the third solution.

15 . The automated peritoneal dialysis apparatus of claim 11 , wherein the at least one pump moves the first solution or the second solution to a heating container that heats the first solution or the second solution to a temperature suitable for delivery to a patient.

16 . The automated peritoneal dialysis apparatus of claim 1 , wherein the first standard UF therapy prescription and the second standard UF therapy prescription are tidal dialysis therapies, continuous cycling peritoneal dialysis (“CCPD”) therapies, or hi-dose CCPD therapies.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 073433/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074041/0750 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2024
From: CHILDERS, ROBERT W.; YU, ALEX ANPING; CIZMAN, BORUT
To: BAXTER INTERNATIONAL INC.; SA, BAXTER HEALTHCARE
Reel/Frame 066214/0321 →
CHANGE OF CORPORATE ADDRESS Recorded Jan 23, 2024
From: BAXTER HEALTHCARE SA
To: BAXTER HEALTHCARE SA
Reel/Frame 066364/0505 →